TB-500

A synthetic peptide based on Thymosin Beta-4, researched for cellular migration, tissue remodeling, angiogenesis, and systemic recovery.

Typical bottle: 10–20 mg

Research note: TB-500 research is largely preclinical. It is best viewed as a tissue-recovery and cellular-remodeling research compound rather than a simple “healing peptide,” and human clinical evidence remains limited.

What It Is

TB-500 is a synthetic peptide based on Thymosin Beta-4, a naturally occurring peptide involved in cellular migration, tissue remodeling, angiogenesis, and repair processes. It has become a popular subject of research involving muscle recovery, connective tissue, mobility, and regenerative biology.

TB-500 is particularly interesting because of its potential influence on actin regulation and cellular migration — two processes that play important roles in tissue repair and remodeling, helping repair-oriented cells reach injured tissue.

Who May Benefit

Muscle and soft-tissue recovery
Tendon and ligament repair research
Cellular migration and tissue remodeling
Angiogenesis and blood-vessel formation research
Flexibility and mobility research
Recovery following physical stress or injury
Connective-tissue and regenerative research
Healthy inflammatory-response pathways

What to Expect

TB-500 is researched as a systemic recovery signal rather than a purely localized one — unlike targeted healing compounds, it circulates and may support multiple areas of repair at once.

Because its research profile centers on cellular migration and remodeling rather than a single mechanism, benefits are generally evaluated over weeks of consistent use alongside proper rehabilitation, training load management, and recovery practices.

What to Pair It With

BPC-157

Frequently paired for broader soft-tissue recovery — BPC for targeted repair, TB-500 for systemic support.

KPV

Research focuses on inflammatory pathway modulation, complementing TB-500’s tissue-remodeling focus.

Cartalax

Investigated for cartilage and connective-tissue health, often incorporated into broader recovery protocols alongside TB-500.

GHK-Cu

Complements TB-500’s remodeling research with collagen production and tissue-repair pathways.

Reconstitution

10 mg Vial

1 mL Bac. Water

20 mg Vial

2 mL Bac. Water

Final Concentration

Same for both

5 units = 500 mcg10 units = 1 mg

Suggested Research Dosing Strategy

Provided Research Reference

500 mcg–1 mg (5–10 units)

Either vial size, once dosed, can be split into 5 days ON / 2 days OFF or spread across 3 injections per week.

The same unit-to-dose relationship applies whether starting from a 10 mg or 20 mg vial reconstituted as above.

Administration Notes

Subcutaneous administration is standard in research protocols.

TB-500 is generally researched as a systemic compound rather than one requiring precise injection at the injury site.

It is frequently investigated alongside other regenerative compounds since tissue recovery involves multiple overlapping biological processes.

Research Considerations

TB-500’s research interest stems from its underlying biology — actin regulation, cell migration, angiogenesis, and tissue remodeling — rather than a single “healing” mechanism.

It is commonly investigated across muscle recovery, tendon/ligament research, mobility, and broader regenerative-biology contexts, often alongside compounds studied for collagen production, cellular repair, and inflammation.

Have a specific question about TB-500? Chat with Pulse, Signal IQ’s free AI research assistant — ask about mechanisms, stacking, or how it compares to other compounds.

For research purposes only. Not approved for human use. This information is provided for educational and research purposes and is not medical advice. Signal IQ does not sell peptides.

All Peptides by Goal